Full bill text rendering is coming soon.
In the meantime, read the full text on Congress.gov ↗.
Core Policy Mechanism Top 5
Congressional review procedure for model expansions
Creates a new process requiring the government to submit Medicare and Medicaid innovation model proposals to Congress, which automatically take effect if Congress does not pass a disapproval resolution within 45 days. Requires the government to provide at least a 45-day public comment period and consult with clinical experts and safety-net providers before testing or expanding Medicare and Medicaid payment innovation models. Allows the government to test healthcare payment models focused solely on improving care quality, even without immediate cost savings, and requires sharing of financial assumptions with providers when approving or rejecting models.
- Population Scope High Medicare and Medicaid together cover over 150 million Americans, and this mechanism governs the approval of all new payment and care delivery models affecting that population.
- Budgetary Magnitude Low No funds are authorized, appropriated, or obligated; the provision restructures decision-making authority without directly moving money.
- Legal / Regulatory Depth High Creates an entirely new statutory default-approval mechanism — a new congressional review procedure with binding expedited legislative procedures — fundamentally restructuring how innovation model expansions acquire legal force.
- Degree of Discretion Granted Medium The Secretary of Health and Human Services (HHS) retains authority to draft and submit proposals, but discretion to finalize model expansions is now structurally conditioned on congressional inaction, reducing unilateral agency latitude.
- Implementation & Enforcement Burden Medium Imposes recurring submission, notice, and consultation obligations on the Secretary of Health and Human Services for every model expansion, creating a standing compliance cycle rather than a one-time administrative action.
- Temporal Commitment High Persists indefinitely as a standing statutory requirement for all future model expansions until Congress acts to repeal it.
No signal yet
Core Policy Mechanism Top 5
Restore judicial review for beneficiary protections
Restores the ability of courts to hear legal challenges to Medicare and Medicaid innovation center decisions when beneficiary protections are at stake, reversing prior limits on judicial review.
- Population Scope Medium Directly affects Medicare and Medicaid beneficiaries enrolled in or subject to innovation models — a substantial but bounded subset of the roughly 150 million total program enrollees.
- Budgetary Magnitude Low No funds are authorized, appropriated, or obligated; the provision alters legal access to courts without directly moving money.
- Legal / Regulatory Depth High Creates a new private right of judicial access where none existed — carving a beneficiary-protection exception into an existing statutory bar and striking subparagraphs that foreclosed review — a substantive expansion of enforceable legal rights.
- Degree of Discretion Granted Low Removes agency discretion by making innovation center decisions subject to external judicial scrutiny, constraining rather than expanding executive latitude.
- Implementation & Enforcement Burden High Shifts enforcement to the federal judiciary, opening the Centers for Medicare & Medicaid Services (CMS) to an indeterminate volume of litigation over beneficiary-protection claims across all tested models.
- Temporal Commitment High Persists indefinitely as a standing statutory entitlement to judicial review until Congress acts to reinstate the prior bar.
No signal yet
Carve-outs, Exemptions, Eligibility Top 5
Repeal Medicare ACO duplication prohibition
Removes a federal rule that barred Medicare accountable care organizations (ACOs) from participating in overlapping payment arrangements, letting ACOs join multiple value-based care models at once.
- Population Scope Low Directly affects Medicare Shared Savings Program accountable care organizations (ACOs) and their participating providers — a narrow, identifiable segment of the broader Medicare ecosystem.
- Budgetary Magnitude Medium Expanding permissible overlap between payment models directly affects Medicare shared savings payment streams, with recurring fiscal implications across all participating ACOs, though no specific dollar amount is specified.
- Legal / Regulatory Depth Medium Strikes an existing statutory prohibition, removing a binding legal constraint on ACO participation arrangements — a targeted repeal that expands permissible conduct without creating new affirmative duties or rights.
- Degree of Discretion Granted High By eliminating the prohibition, ACOs and the Secretary of Health and Human Services (HHS) gain broad new latitude to structure multi-model participation arrangements without prior statutory restriction.
- Implementation & Enforcement Burden Low Removes a prohibition rather than adding new compliance obligations, net-reducing the enforcement footprint for this population.
- Temporal Commitment High Persists indefinitely as a permanent repeal of the prior prohibition until Congress acts to reinstate it.
No signal yet
Regulatory or Legal Changes Top 5
Phase I model testing scope and duration limits
Caps Medicare and Medicaid innovation model Phase I testing at five years and 500,000 beneficiaries, limits new models initiated per year, and restricts concurrent mandatory-participation models, reducing the scale of agency-run experiments. Requires the government to create a hardship waiver process for providers harmed by innovation model rules and a real-time monitoring plan to detect and reduce negative effects on patient care.
- Population Scope Medium The 500,000-beneficiary cap and annual model limits directly constrain enrollment in innovation models, affecting a significant but bounded share of Medicare and Medicaid enrollees at any given time.
- Budgetary Magnitude Low No funds are authorized, appropriated, or obligated; the caps constrain program activity without directly appropriating or restricting money.
- Legal / Regulatory Depth Medium Imposes new statutory caps and mandatory hardship-waiver and monitoring duties on the Secretary of Department of Health and Human Services (HHS), constraining existing agency discretion through binding procedural and numerical limits rather than creating new substantive rights.
- Degree of Discretion Granted Medium The Secretary of Health and Human Services retains discretion over which models to initiate and how to design waivers and monitoring plans, but within tightly bounded statutory ceilings on duration, enrollment, and model count.
- Implementation & Enforcement Burden Medium Standing up a hardship waiver adjudication process and real-time monitoring infrastructure imposes recurring case-by-case administrative obligations on Centers for Medicare & Medicaid Services (CMS).
- Temporal Commitment High Persists indefinitely as binding statutory limits on all future Phase I model testing activity until Congress acts to amend them.
No signal yet
Regulatory or Legal Changes Top 5
CMI geographic limit amendment for existing models
Requires the government to account for already-running payment models in a geographic area before setting limits on new innovation models in that same area, reducing program overlap.
- Population Scope Low Directly affects providers and beneficiaries in geographic areas where innovation models overlap — a narrow, location-specific subset of the broader Medicare and Medicaid population.
- Budgetary Magnitude Low No funds are authorized, appropriated, or obligated; the provision adds a decision-making consideration without directly moving money.
- Legal / Regulatory Depth Medium Amends the statutory standard the Secretary of Health and Human Services (HHS) must apply when setting geographic limits, imposing a new mandatory consideration that constrains but does not eliminate agency discretion over model geography.
- Degree of Discretion Granted Medium The Secretary of Health and Human Services must now account for existing models when drawing geographic limits but retains discretion over how to weigh that factor and where to set the boundaries.
- Implementation & Enforcement Burden Low Adds a single decision-making requirement to an existing administrative process without creating new enforcement mechanisms or compliance obligations.
- Temporal Commitment High Persists indefinitely as a standing statutory requirement governing all future geographic limit determinations until Congress acts to remove it.
No signal yet
No possible riders have been surfaced for this bill.
Summary
This bill changes how the Centers for Medicare & Medicaid Services (CMS) tests and expands new payment and care delivery models through its innovation center. It adds oversight from Congress and the public to a process that has historically operated with broad agency discretion. Among other elements, the bill * limits the size and number of new innovation models CMS can run at once, and requires hardship waivers and real-time monitoring to protect patients; * creates a congressional review process where model expansions take effect automatically unless Congress passes a disapproval resolution within 45 days; * requires public notice-and-comment periods and consultations with clinical experts and safety-net providers before models move forward; * restores the ability of courts to review innovation center decisions that affect Medicare and Medicaid beneficiaries; * broadens the types of models CMS can test, including quality-focused models without immediate cost savings, and requires disclosure of the financial assumptions behind model approvals; * and addresses overlap between value-based care programs by adjusting geographic rules and removing a restriction on accountable care organizations (ACOs) participating in multiple payment models.
AI-generated summary, pending human review.
| Version | Event | Date | User support | Your vote | Roll calls |
|---|---|---|---|---|---|
| Original |
Initial publication
Oct 1, 2026
|
Oct 1, 2026 | No votes yet | — | — |
Log in or create an account to record your vote on this legislation. Results are visible to all visitors.
Core Policy Mechanism Top 5
Congressional review procedure for model expansions
Creates a new process requiring the government to submit Medicare and Medicaid innovation model proposals to Congress, which automatically take effect if Congress does not pass a disapproval resolution within 45 days. Requires the government to provide at least a 45-day public comment period and consult with clinical experts and safety-net providers before testing or expanding Medicare and Medicaid payment innovation models. Allows the government to test healthcare payment models focused solely on improving care quality, even without immediate cost savings, and requires sharing of financial assumptions with providers when approving or rejecting models.
- Population Scope High Medicare and Medicaid together cover over 150 million Americans, and this mechanism governs the approval of all new payment and care delivery models affecting that population.
- Budgetary Magnitude Low No funds are authorized, appropriated, or obligated; the provision restructures decision-making authority without directly moving money.
- Legal / Regulatory Depth High Creates an entirely new statutory default-approval mechanism — a new congressional review procedure with binding expedited legislative procedures — fundamentally restructuring how innovation model expansions acquire legal force.
- Degree of Discretion Granted Medium The Secretary of Health and Human Services (HHS) retains authority to draft and submit proposals, but discretion to finalize model expansions is now structurally conditioned on congressional inaction, reducing unilateral agency latitude.
- Implementation & Enforcement Burden Medium Imposes recurring submission, notice, and consultation obligations on the Secretary of Health and Human Services for every model expansion, creating a standing compliance cycle rather than a one-time administrative action.
- Temporal Commitment High Persists indefinitely as a standing statutory requirement for all future model expansions until Congress acts to repeal it.
No signal yet
Core Policy Mechanism
Congressional review procedure for model expansions
Core Policy Mechanism Top 5
Restore judicial review for beneficiary protections
Restores the ability of courts to hear legal challenges to Medicare and Medicaid innovation center decisions when beneficiary protections are at stake, reversing prior limits on judicial review.
- Population Scope Medium Directly affects Medicare and Medicaid beneficiaries enrolled in or subject to innovation models — a substantial but bounded subset of the roughly 150 million total program enrollees.
- Budgetary Magnitude Low No funds are authorized, appropriated, or obligated; the provision alters legal access to courts without directly moving money.
- Legal / Regulatory Depth High Creates a new private right of judicial access where none existed — carving a beneficiary-protection exception into an existing statutory bar and striking subparagraphs that foreclosed review — a substantive expansion of enforceable legal rights.
- Degree of Discretion Granted Low Removes agency discretion by making innovation center decisions subject to external judicial scrutiny, constraining rather than expanding executive latitude.
- Implementation & Enforcement Burden High Shifts enforcement to the federal judiciary, opening the Centers for Medicare & Medicaid Services (CMS) to an indeterminate volume of litigation over beneficiary-protection claims across all tested models.
- Temporal Commitment High Persists indefinitely as a standing statutory entitlement to judicial review until Congress acts to reinstate the prior bar.
No signal yet
Core Policy Mechanism
Restore judicial review for beneficiary protections
Carve-outs, Exemptions, Eligibility Top 5
Repeal Medicare ACO duplication prohibition
Removes a federal rule that barred Medicare accountable care organizations (ACOs) from participating in overlapping payment arrangements, letting ACOs join multiple value-based care models at once.
- Population Scope Low Directly affects Medicare Shared Savings Program accountable care organizations (ACOs) and their participating providers — a narrow, identifiable segment of the broader Medicare ecosystem.
- Budgetary Magnitude Medium Expanding permissible overlap between payment models directly affects Medicare shared savings payment streams, with recurring fiscal implications across all participating ACOs, though no specific dollar amount is specified.
- Legal / Regulatory Depth Medium Strikes an existing statutory prohibition, removing a binding legal constraint on ACO participation arrangements — a targeted repeal that expands permissible conduct without creating new affirmative duties or rights.
- Degree of Discretion Granted High By eliminating the prohibition, ACOs and the Secretary of Health and Human Services (HHS) gain broad new latitude to structure multi-model participation arrangements without prior statutory restriction.
- Implementation & Enforcement Burden Low Removes a prohibition rather than adding new compliance obligations, net-reducing the enforcement footprint for this population.
- Temporal Commitment High Persists indefinitely as a permanent repeal of the prior prohibition until Congress acts to reinstate it.
No signal yet
Carve-outs, Exemptions, Eligibility
Repeal Medicare ACO duplication prohibition
Regulatory or Legal Changes Top 5
Phase I model testing scope and duration limits
Caps Medicare and Medicaid innovation model Phase I testing at five years and 500,000 beneficiaries, limits new models initiated per year, and restricts concurrent mandatory-participation models, reducing the scale of agency-run experiments. Requires the government to create a hardship waiver process for providers harmed by innovation model rules and a real-time monitoring plan to detect and reduce negative effects on patient care.
- Population Scope Medium The 500,000-beneficiary cap and annual model limits directly constrain enrollment in innovation models, affecting a significant but bounded share of Medicare and Medicaid enrollees at any given time.
- Budgetary Magnitude Low No funds are authorized, appropriated, or obligated; the caps constrain program activity without directly appropriating or restricting money.
- Legal / Regulatory Depth Medium Imposes new statutory caps and mandatory hardship-waiver and monitoring duties on the Secretary of Department of Health and Human Services (HHS), constraining existing agency discretion through binding procedural and numerical limits rather than creating new substantive rights.
- Degree of Discretion Granted Medium The Secretary of Health and Human Services retains discretion over which models to initiate and how to design waivers and monitoring plans, but within tightly bounded statutory ceilings on duration, enrollment, and model count.
- Implementation & Enforcement Burden Medium Standing up a hardship waiver adjudication process and real-time monitoring infrastructure imposes recurring case-by-case administrative obligations on Centers for Medicare & Medicaid Services (CMS).
- Temporal Commitment High Persists indefinitely as binding statutory limits on all future Phase I model testing activity until Congress acts to amend them.
No signal yet
Regulatory or Legal Changes
Phase I model testing scope and duration limits
Regulatory or Legal Changes Top 5
CMI geographic limit amendment for existing models
Requires the government to account for already-running payment models in a geographic area before setting limits on new innovation models in that same area, reducing program overlap.
- Population Scope Low Directly affects providers and beneficiaries in geographic areas where innovation models overlap — a narrow, location-specific subset of the broader Medicare and Medicaid population.
- Budgetary Magnitude Low No funds are authorized, appropriated, or obligated; the provision adds a decision-making consideration without directly moving money.
- Legal / Regulatory Depth Medium Amends the statutory standard the Secretary of Health and Human Services (HHS) must apply when setting geographic limits, imposing a new mandatory consideration that constrains but does not eliminate agency discretion over model geography.
- Degree of Discretion Granted Medium The Secretary of Health and Human Services must now account for existing models when drawing geographic limits but retains discretion over how to weigh that factor and where to set the boundaries.
- Implementation & Enforcement Burden Low Adds a single decision-making requirement to an existing administrative process without creating new enforcement mechanisms or compliance obligations.
- Temporal Commitment High Persists indefinitely as a standing statutory requirement governing all future geographic limit determinations until Congress acts to remove it.
No signal yet
Regulatory or Legal Changes
CMI geographic limit amendment for existing models
Incomplete vote
You have not made a selection on all required items:
Choose Neutral if you prefer not to commit. Leaving without completing will remove all your votes for this bill from the totals.
Maximum recommendations reached
You have already recommended the maximum number of components allowed on this bill. To recommend [new component], choose one of your current recommendations to unselect: